Knowledge Center

Filter your results:

Type

Topic

144 Results Found

Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Cost, Quality and Outcomes (CQO) Movement, Data Standards, Materials Management Information System (MMIS), Regulations and Regulatory Advocacy, Suppliers, Leadership
Advisory
National Provider Call: Hospital Value-Based Purchasing
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
Change Management, Cost, Quality and Outcomes (CQO) Movement, Lean/Six Sigma, Strategic Planning
Senior Contract Specialist
Senior Contract Specialist job description.
Capital Equipment, Clinical Resource Management (CRM), Cost Management, Cost, Quality and Outcomes (CQO) Movement, Physician Preference Items (PPI), Strategic Sourcing, Value Analysis
Advisory
UDI and Adverse Event Reporting Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years. The first sunrise date (certain Class III devices) occurred 09/24/14. Recognizing UDI implementation will take time, healthcare supply chain and risk management professionals should be aware of already-implemented changes in the FDA’s adverse event reporting methodology. One of the changes required immediately is the use of the UDI in adverse event reporting.
Cost, Quality and Outcomes (CQO) Movement, Logistics